Beginning July 20, 2023, pharmacies will be required to report Naloxone dispensing to the PDMP (Prescription Drug Monitoring Program) because of passage of a 2022 law. Additionally, the PDMP is changing certain ASAP (American Society for Automation in Pharmacy) fields from “optional” to “required.” For more information, see the updated PDMP RxGov Data Submitter Reference Guide with changes dictated by the naloxone statute, changes to required fields and new guidance from ASAP for v4.2A & v4.2B.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.